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Abstract
Background: Long-term care facilities (LTCF) are potential reservoirs for methicillin-resistant Staphylococcus aureus
(MRSA), control of which may reduce MRSA transmission and infection elsewhere in the healthcare system.
Whole-genome sequencing (WGS) has been used successfully to understand MRSA epidemiology and transmission
in hospitals and has the potential to identify transmission between these and LTCF.
Methods: Two prospective observational studies of MRSA carriage were conducted in LTCF in England and Ireland.
MRSA isolates were whole-genome sequenced and analyzed using established methods. Genomic data were
available for MRSA isolated in the local healthcare systems (isolates submitted by hospitals and general
practitioners).
Results: We sequenced a total of 181 MRSA isolates from the two study sites. The majority of MRSA were
multilocus sequence type (ST)22. WGS identified one likely transmission event between residents in the English
LTCF and three putative transmission events in the Irish LTCF. WGS also identified closely related isolates present in
colonized Irish residents and their immediate environment. Based on phylogenetic reconstruction, closely related
MRSA clades were identified between the LTCF and their healthcare referral network, together with putative MRSA
acquisition by LTCF residents during hospital admission.
Conclusions: These data confirm that MRSA is transmitted between residents of LTCF and is both acquired and
transmitted to others in referral hospitals and beyond. Our data present compelling evidence for the importance of
environmental contamination in MRSA transmission, reinforcing the importance of environmental cleaning. The use
of WGS in this study highlights the need to consider infection control in hospitals and community healthcare
facilities as a continuum.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) is a
major cause of community- and healthcare-associated
infections worldwide [1]. Infection typically occurs in in-
dividuals who are colonized with MRSA [2] and control
measures to reduce infection rates largely revolve
around the prevention of MRSA acquisition by non-
carriers. In the United Kingdom (UK) and Ireland, rates
of MRSA bacteremia have been reduced by more than
85 and 60 % in the past decade, respectively, following
the introduction of mandatory surveillance and numer-
ous infection control measures [3, 4]. This has led to
calls for a zero tolerance approach to MRSA bacteremia
[5]. Achieving further reductions requires consideration
of residual reservoirs of MRSA carriage and activities as-
sociated with transmission [3].
Community-based long-term care facilities (LTCF) are
an important reservoir for MRSA since rates of MRSA
carriage may exceed 50 %, compared with a carriage rate
of ~1.5 % in the general population in both the UK and
USA [6, 7]. Frequent antibiotic consumption, indwelling
devices, and the presence of chronic conditions in LTCF
residents contribute to these higher carriage rates [8, 9].
Furthermore, the need to provide a homely environment
combined with care of individuals with cognitive impair-
ment poses challenges to effective infection control [10].
LTCF residents also have frequent contact with health-
care providers in hospitals and primary care, which rep-
resent opportunities for both onward transmission of
MRSA and new acquisition events [11, 12].
Defining the extent to which LTCF contribute to the
overall burden of MRSA acquisition and infection neces-
sitates comparative genotyping of MRSA isolates from
across healthcare networks. The use of standard geno-
typing methods such as multilocus sequence typing
(MLST) has confirmed that MRSA in LTCF belong to a
limited number of predominantly hospital-associated lin-
eages [13, 14]. Existing methods do not, however, have
sufficient resolution to delineate MRSA transmission
within LTCF and between these and their associated
healthcare network. Whole-genome sequencing (WGS)
provides a solution to this problem and is being increas-
ingly used to investigate the epidemiology and transmis-
sion of a range of bacterial pathogens [15–18]. Here, we
describe the application of WGS to determine the fre-
quency with which MRSA is transmitted between LTCF
residents and their environment and is acquired and
transmitted to others in referral hospitals and beyond.
Methods
Study design and sampling
We conducted two independent prospective observa-
tional studies of MRSA carriage in LTCF. The first was
conducted in a 100-bed facility in Galway, Ireland
between July 2012 and August 2013. The second was
conducted in a 105-bed facility in Cambridge, UK over
27 weeks in 2014. Each LTCF consisted of four (Galway)
or five (Cambridge) separate units to which residents
were assigned based on cognitive impairment and nurs-
ing needs [19]. Data were collected from medical records
and nursing care plans. This included demographics
(age, gender, unit of residence), residence prior to admis-
sion to the study facility, a history of MRSA carriage or
infection in the 12 months prior to enrolment and dur-
ing the study period, and hospital contact over the same
time scale. MRSA screening was performed at enrolment
and then weekly (Cambridge) or quarterly (Galway) until
the end of the study, participant discharge, or death.
This was achieved by taking nasal (Galway) or multisite
(nares and groin; Cambridge) screening swabs. No clin-
ical MRSA infections were reported to the study investi-
gators during the study period at either site.
Environmental sampling
Environmental MRSA sampling was performed on four
separate occasions as part of the Galway study, as previ-
ously described [19]. In brief, 9 months before the car-
riage study began, residents were transferred as a cohort
from a pre-existing facility to a newly constructed resi-
dence. Multiple swabs of environmental surfaces were
collected in communal and bedroom areas in the old
and new facilities. This was done once in August 2011
in the old facility (denoted as environmental sample (ES)
1) and three times in the new facility (the study site), be-
fore moving in (ES2, August 2011) and before and after
completion of the carriage study (ES3, November 2011
and ES4, August 2013, respectively) [19]. Environmental
samples were processed and MRSA recovered from 94/
270 (35 %) samples, as described previously [19], 24 of
which were selected for WGS based on spread over time
and genetic diversity as defined by previous MLST se-
quence type (ST) [19].
Microbiology and bacterial isolates
In Cambridge, screening swabs were plated directly onto
selective chromogenic MRSA medium (Brilliance
MRSA2, Oxoid, Basingstoke, UK), incubated at 37 °C in
air, and examined for MRSA growth after 24 h. S. aureus
was identified using a latex agglutination test kit (Pas-
torex Staph Plus, Bio Rad Laboratories, Hemel Hemp-
stead, UK). Isolates were confirmed as methicillin-
resistant using cefoxitin, EUCAST methodology, and in-
terpretive criteria [20]. Swabs taken in Galway were
processed as described previously [19]. MRSA isolated
from clinical samples by the diagnostic microbiology la-
boratory at Galway University Hospital between Oct
2011 and Nov 2011 (time of initial environmental
screening) and Oct 2012 and Aug 2013 (time of patient
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study) were identified using the laboratory database.
Thirty-seven isolates from 31 hospital patients in 2011
(n = 4), 2012 (n = 6), and 2013 (n = 27) were retrieved
from frozen stock.
Sequencing and analysis
Bacterial DNA was extracted and sequenced on an Illu-
mina HiSeq2000 with 100-cycle paired-end runs. Se-
quence data have been submitted to the European
Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena)
under the accession numbers listed in Additional file 1.
Sequence data were assembled using the pipeline de-
scribed in [21]. For each isolate the sequence reads were
used to create multiple assemblies using VelvetOptimi-
ser v2.2.5 [22] and Velvet v1.2 [23]. The assemblies were
improved by scaffolding the best N50 and contigs using
SSPACE [24] and sequence gaps filled using GapFiller
[25]. Sequence types were determined from the assemblies
using MLST check (https://github.com/sanger-pathogens/
mlst_check), which was used to compare the assembled
genomes against the MLST database for S. aureus (http://
pubmlst.org/saureus/). SCCmec typing was carried out as
previously described [26] using in silico PCR against velvet
assemblies and published primers [27, 28]. Sequence reads
were mapped to a relevant reference genome ENA ST22
(strain HO 5096 0412, accession number HE681097), ST5
(strain N315, accession number BA000018) or ST45
(strain CA347, accession number CP006044) using
SMALT (http://www.sanger.ac.uk/science/tools/smalt-0)
following default settings to identify single nucleotide
polymorphisms (SNPs). SNPs located in mobile genetic el-
ements were removed from the alignments and a max-
imum likelihood tree created using RAxML following
default settings and 100 bootstrap replicates [29]. The
ST22 isolates from Ireland and Cambridge were rooted
using isolate MSSA476, as previously reported [30]. Trees
with bootstraps values are presented in Additional files 2
and 3 for Galway and Cambridge, respectively. We also
accessed genome sequence data for MRSA identified by
the microbiology laboratory at Cambridge University Hos-
pitals NHS Foundation Trust (Cambridge, UK) between
April 2012 and April 2013 (2384 isolates from 1480 pa-
tients) (S. Peacock, personal communication). Ethical ap-
proval for this collection was given by the National
Research Ethics Service (ref. 11/EE/0499), the National In-
formation Governance Board Ethics and Confidentiality
Committee (ref ECC 8-05 (h)/2011), and the Cambridge
University Hospitals NHS Foundation Trust Research and
Development Department (ref. A092428).
Results
Study participants
Sixty-four of 117 (55 %) residents at the Galway facility
(Galway resident (GR)) and 45 of 90 (50 %) residents at
the Cambridge facility (Cambridge resident (CR)) were
recruited. Baseline characteristics of the two study
groups are summarized in Table 1. No patients were
known to have had an MRSA infection during the study.
Seventeen participants in the Galway study died during
the study and three participants were lost from the
Cambridge study due to death (n = 2) or transfer to an-
other facility (n = 1).
MRSA carriage and phylogeny
In Galway, nasal swabs taken every three months for
one year showed that 17 of 64 participants (27 %) were
positive for MRSA in a total of 35 samples (Fig. 1a). The
temporal pattern of carriage is shown in Fig. 1a. Se-
quence data were used to assign the ST to each isolate,
which revealed the presence of two lineages: CC22 (n =
28) and CC5 (n = 6) (one isolate was unrecoverable for
sequencing). A phylogenetic tree based on core genome
SNPs of the ST22 isolates demonstrated multiple dis-
tinct clades (Fig. 1b). Two participants (GR05 and
GR06) carrying ST22 had clade replacement over time
or carried a mixed population. The clade identified from
the first swab from GR05 (GR05A) was distinct from
their later swabs (GR05B, C, and D) and the clade from
the first two swabs from GR06 (GR06A and GR06B) was
distinct from the isolate from their third swab (GR06C)
(Fig. 1b). Three putative transmission events were identi-
fied based on genetic relatedness (<40 SNP; 40 SNPs is
the maximum number of SNPs identified in sequencing of
multiple colonies from a single individual [31]) and epi-
demiology. Two isolates from GR06 (GR06A and GR06B)
and GR12 (GR12A and GR12B) were closely related with
a maximum pairwise SNP distance of nine and both GR06
and GR12 were residents of the same unit (unit 1). Three
more unit 1 residents (GR01, GR03, GR05) had isolates
that resided in a cluster of highly related isolates that
Table 1 Summary of study participants
Characteristic Galway
(n = 64)
Cambridge
(n = 45)
Female (n (%)) 30 (47 %) 29 (64 %)
Age (years), median (range, IQR) 80 (37–98,
9.25)
82 (40–104,
71–87)
Residence prior to admission (n (%))
Home 39 (61 %) 7 (16 %)
Hospital 6 (9 %) 17 (38 %)
Other residential care 19 (30 %) 21 (47 %)
Hospital contact in 12 months before
recruitment (n (%))
11 (17 %) 26 (58 %)
Hospital contact during study (n (%)) 37 (58 %) 6 (14 %)
Known MRSA carriage or infection in 12-
month period before recruitment (n (%))
9 (14 %) 3 (7 %)
IQR interquartile range
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differed from each other by ~20 SNPs. A transmission
event was also suggested for ST5 isolates; isolates from
GR07 and GR13 had a maximum pairwise SNP distance
of 15 (Additional file 4), the isolate from GR07 cultured
6 months before those from GR13 being basal in the clus-
ter with GR13A and GR13B. However, these two residents
lived on two different units located upstairs and down-
stairs in the home—unit 1 for GR07 and unit 4 for
GR013—and GR07 was also immobile, indicating possible
indirect transmission.
In Cambridge, 6 of 45 (14 %) participants were positive
for MRSA in a total of 70 samples (Fig. 2a), all of which
were ST22. Phylogenetic analysis demonstrated five dis-
tinct clades, each separated by at least 80 SNPs (Fig. 2b).
Each participant was colonized by a distinct clade with
the exception of CR02 and CR06, who carried the same
clade. Furthermore, the single isolate from CR06 was
nested in the cluster containing 24 isolates from CR02
with a two-SNP difference from the most closely related
CR02 isolate, suggestive of a transmission event (Fig. 2b).
This was further support by the fact that CR02 and
CR06 both live in the same unit (unit 1). Evidence for
acquisition of MRSA within the LTCF was observed for
CR15, who became MRSA-positive after 12 negative
screens (Fig 2). This individual carried a genetic lineage
that was not closely related to other isolates; they did
not have outside healthcare contact during the study
and MRSA was presumably acquired from an unsampled
carrier. Three participants (CR15, CR42, and CR43) were
intermittently positive for MRSA, but each carried the
same or highly related lineage either side of two con-
secutive negative swabs.
Environmental contamination
The 24 environmental MRSA isolates from the four epi-
sodes of sampling that were sequenced belonged to
Fig. 1 The epidemiology and phylogeny of MRSA in the Galway study facility. a Time line of positive and negative swabs. Blue, pink, and orange
shapes representing ST22, ST5, and an MRSA-positive sample that could not be recovered on re-culture, respectively. b Maximum likelihood tree
generated from core genome SNPs of ST22 MRSA isolates from the Galway LTCF residents (blue), environmental swabs (black), and isolates from
Galway University Hospital (red). The outgroup is MSSA476. A tree with bootstrap values is shown in Additional file 1
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ST22 (n = 18) or ST45 (n = 6). ST45 was not isolated
from participants, yet was cultured from patient rooms
(bedframes and lockers) in the old and new facilities
(ES1, ES3) and shared areas (toilet flush, shower handle,
and door handle in a common bathroom) in the new
building (ES3), forming one cluster (Additional file 5).
We assume that an unsampled resident, staff member,
or visitor carried ST45. Comparison of the genetic re-
latedness of ST22 cultured from residents and the envir-
onment revealed several instances in which lineages
were shared between the two. For example, GR15 car-
ried MRSA that was also present in their immediate en-
vironment (ES4_15B; Fig. 1b). A striking example of
environmental contamination was the finding that a car-
riage isolate from GR10 (GR10A) was highly related (five
SNPs different) to an environmental isolate from the
study facility before it was commissioned for use
(ES2_53A). We also noted a cluster formed by MRSA
carried by GR09 and isolated from both the old
(ES1_50) and new facilities (ES3_56A) (Fig 1b). Eight
genetically distinct ST22 isolates or clusters were iso-
lated from the environment alone, which may have origi-
nated from unsampled residents, staff, or visitors.
Relatedness of MRSA within healthcare networks
Next, we compared the genetic relatedness of MRSA
from residents of the LTCF and MRSA isolated from
elsewhere in the same healthcare network. In Galway,
we obtained and sequenced 37 MRSA isolated from clin-
ical samples taken from hospital in-patients at Galway
University Hospital (GUH). These were assigned to nine
different STs: ST22 (n = 25), a single locus variant of ST22
(n = 1), ST5 (n = 1), a single locus variant of ST5 (n = 1),
ST779 (n = 4), ST8 (n = 2), ST45 (n = 1), ST88 (n = 1), and
ST1 (n = 1). The 27 isolates with STs represented in both
the hospital and LTCF carriage collections (CC22 and
CC5) were included in further phylogenetic analysis; the
hospital isolates were cultured from 21 patients with
Fig. 2 The epidemiology and phylogeny of MRSA in the Cambridge LTCF. a Time line of positive and negative swabs, with blue shapes
representing ST22 isolates. b Maximum likelihood tree generated from core genome SNPs of MRSA isolates from the Cambridge LTCF (blue) and
closely related isolates from Cambridge University Hospitals NHS Foundation Trust or Hinchingbrooke Health Care NHS Trust (red). The outgroup
is MSSA476. A tree with bootstraps values is shown in Additional file 2
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bacteremia (n = 17), deep site infection (n = 3), or a wound
surface swab (n = 1). The phylogeny of MRSA genomes
from the two settings indicated distinct bacterial popula-
tions, with two exceptions. Carriage isolates from GR04
and an isolate cultured from a hospital patient (GUH26,
Jan 2013) were highly related (ten SNPs different) (Fig. 1b).
Resident GR04 was admitted to GUH in the year before
the carriage study started, suggesting initial acquisition at
the hospital or onward transmission to others at that time
(Fig. 1b). ST5 isolates from residents GR07 and GR13
were also related to an isolate from GUH34 (25 SNPs
different; Additional file 4). Both GR07 and GR13 were
admitted to GUH in the year before the study began.
A comparative analysis was also performed between
carriage isolates from the Cambridge LTCF and an ex-
tensive, unbiased collection of all ST22 MRSA cultured
at the diagnostic microbiology laboratory at Cambridge
University Hospitals NHS Foundation Trust (CUH)
from April 2012 to April 2013. This laboratory receives
samples from three hospitals (CUH and Hinchingbrooke
Hospital (HIN), and Papworth hospital) and GPs in the
region. We identified 1132 CC22 isolates from this col-
lection, which were combined in a phylogenetic tree
with the Cambridge LTCF isolates, and used a cutoff of
50 SNPs (10 SNPs greater than the maximum number
of 40 SNPs, found with isolates from a single individual
[31–33]) to identify the most closely related MRSA from
the diagnostic laboratory. This identified 16 MRSA iso-
lates from ten patients at the CUH (n = 7), HIN (n = 2),
and GPs’ practices (n = 2), which were related to carriage
isolates from residents CR02, CR06, CR15, and CR42
(Fig. 2b). A case note review revealed that hospital pa-
tient CUH506 and resident CR42 were the same person.
Isolation of their hospital strain occurred 18 months
prior to detection of carriage during the study, suggest-
ing that CR42 was admitted to the LTCF carrying this
clade. A link between resident CR02 and a cluster of iso-
lates from patient (P)33 and P728 was explained by mul-
tistep transmission events (Fig. 2b). CR02 and P33 had
both previously resided in the same LTCF (different to
the study site), where a presumed transmission event
took place. P33, P728, and P1070 were all admitted to
HIN during 2012, strongly indicating that this clone was
circulating in that hospital. Even though CR15 had no
hospital contact during the study period, their isolates
(A–F) were closely related to an isolate from P428 who
died in CUH in July 2012 (Fig. 2b). Two of the four iso-
lates basal to the isolate from P428 were from two other
patients (P581 and P524), who along with P428 were
residents in another Cambridge LTCF.
Discussion
Our study provides a genome-based view of MRSA
carriage and transmission within LTCF and between
these and referral hospitals. Our findings are consist-
ent with high rates of MRSA carriage compared with
hospital populations, on-going MRSA transmission
between LTCF residents, and acquisition and onward
transmission of MRSA during hospital admission. Our
study also provides further evidence to suggest that
the environment might represent an important MRSA
transmission pathway. Rates of MRSA carriage in
both LTCF were comparable to previously reported
prevalence rates of 23.3 % in Northern Ireland (95 %
confidence interval (CI) 18.8–27.7 %) and 19–22 % in
Leeds, UK [14, 34]. The predominance of ST22 in
both LTCF is consistent with previous studies in UK
and Irish healthcare settings [30, 35]. Delineation of
numerous ST22 clades in each facility is also consist-
ent with previous reports of the discriminatory power
of WGS [15, 17, 33].
WGS data provided strong evidence for on-going
MRSA transmission within the study LTCF and hos-
pitals. This was particularly observed in the Irish fa-
cility, in which seven residents shared closely related
isolates with other residents. We noted that five of
the six MRSA colonized Cambridge participants and
16 of the 17 colonized Galway participants had been
in hospital in the previous year, confirming the po-
tential for onward transmission and indicating an
important infection control target. WGS identified
that a Cambridge resident (CR42) carried an ST22
clade that was isolated during two hospital admis-
sions and associated with infection approximately
18 months previously, suggesting ineffective MRSA
decolonization protocols in known MRSA carriers.
We found evidence for putative MRSA acquisition
during hospital admission in the Galway study, in
that three residents were hospitalized in the previous
year and subsequently were colonized with MRSA
clones found to be circulating in GUH.
We identified multiple instances where MRSA carriage
in an individual was highly related to environmental
MRSA from their single room or communal areas, as
has been reported by WGS-based studies in hospitals
[36, 37]. Eight ST22 clades and four ST45 clades were
identified from the environment alone, which may be at-
tributable to carriage of these lineages by unsampled res-
idents or staff. ST22 has been reported to survive for
weeks on abiotic surfaces and has been identified in hos-
pital surfaces and on public buses [38, 39]. Additionally,
both ST45 and the ST8 clone USA300 have been shown
to play a role in environmental contamination and
household transmission [40, 41]. Taken together, this
suggests that the environment may be an important
source for MRSA transmission and a barrier to effective
infection control in LTCF, which is consistent with pre-
vious studies showing that cleaning can reduce
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environmental MRSA contamination and infection rates
in hospitals [42].
We found no direct evidence for the introduction of
MRSA into hospitals by our study participants, which
might be expected given the study design, although the
relatedness of study facility and hospital MRSA popula-
tions indicates that these are shared. We also captured
the complexity of MRSA acquisition and transmission
across healthcare networks, as highlighted by the trans-
mission network between a Cambridge resident (CR02)
and a cluster of hospital isolates from individuals who
had shared a different community-based care home
(P33) and had been admitted to the same hospital (P33,
P728, and P1070). This putative transmission network
exemplifies the complex inter-connectivity of hospitals
and community-based care facilities. A similar epidemi-
ology picture was observed for vancomycin-resistant En-
terococcus faecium in the same Cambridge LTCF [43],
demonstrating that the overlapping epidemiology be-
tween hospital and LTCF is likely common to most non-
nosocomial pathogens.
We acknowledge several study limitations. Some
participants carried different ST22 lineages over
time, representing possible clade replacement or car-
riage of more than one lineage or clade. Sequencing
was based on DNA extracted from a pure culture of
a single colony. Serial sampling of individuals par-
tially addresses this bias, but distinguishing between
these two possibilities requires sequencing of mul-
tiple independent colonies from the primary culture
plate [33]. Studies using both spa-typing and WGS
have confirmed carriage of more than one strain [33,
44], although the frequency with which this occurs
in different settings is not known. Furthermore, only
the nares were sampled in the Galway study and the
nares and groin in the Cambridge study, thus ex-
cluding MRSA carriers solely colonized at other
body sites [45]. A further limitation is that only ap-
proximately 50 % of residents were recruited and
sampled in both study sites and staff members were
not screened, reducing the power to detect transmis-
sion. Many participants in both studies were immo-
bile and understanding the pattern of staff MRSA
carriage may shed light on the contribution of
healthcare workers to the transmission dynamics of
MRSA in LTCF.
Conclusions
Our study confirms that LTCF are reservoirs for MRSA
strains that are closely related to hospital strains of MRSA,
the comparable results from two different geographical
settings adding weight to these findings. This provides fur-
ther evidence for the need for infection control policies
that jointly consider hospitals and community healthcare
facilities.
Additional files
Additional file 1: Isolates and associated metadata included in this
study. (XLSX 47 kb)
Additional file 2: Phylogeny of CC22 MRSA in the Galway study facility
with bootstrap values. Bootstrap values for branches are shown in grey.
(PDF 197 kb)
Additional file 3: Phylogeny of CC22 MRSA in the Cambridge LTCF
with bootstrap values. Bootstrap values for branches are shown in grey.
(PDF 224 kb)
Additional file 4: Phylogeny of CC5 MRSA in the Galway study.
Maximum likelihood tree generated from core genome SNPs of CC5
MRSA isolates from the Galway LTCF residents (blue) and isolates from
Galway University Hospital (red). Bootstrap values for branches are shown
in grey. (PDF 266 kb)
Additional file 5: Phylogeny of ST45 MRSA in the Galway study. a
Maximum likelihood tree generated from core genome SNPs of ST45
MRSA isolates from the Galway LTCF environment (black) and the isolate
from Galway University Hospital (red). b Zoomed in view of the isolates
from the Galway LTCF. Bootstrap values for branches are shown in grey.
(PDF 23 kb)
Abbreviations
CR: Cambridge resident; CUH: Cambridge University Hospitals NHS
Foundation Trust; ENA: European Nucleotide Archive; ES: Environmental
sample; GP: General practitioner; GR: Galway resident; GUH: Galway University
Hospital; HIN: Hinchingbrooke Hospital; LTCF: Long-term care facility;
MLST: Multilocus sequence typing; MRSA: Methicillin-resistant Staphylococcus
aureus; P: Patient; SNP: Single nucleotide polymorphism; ST: Multilocus
sequence type; WGS: Whole-genome sequencing
Acknowledgments
We gratefully acknowledge the contribution of the care staff at the
Cambridge and Galway study facilities in sample collection and thank all of
the patients who participated. We thank Kirsty Ambridge, Angela Kidney, and
the Microbiology staff at Galway University Hospital for technical assistance
in the laboratory. We are grateful for assistance from the library construction,
sequencing, and core informatics teams at the Wellcome Trust Sanger
Institute.
Funding
The study was supported by grants from the UKCRC Translational Infection
Research (TIR) Initiative and the Medical Research Council (grant number
G1000803) with contributions to the grant from the Biotechnology and
Biological Sciences Research Council, the National Institute for Health
Research on behalf of the Department of Health, and the Chief Scientist
Office of the Scottish Government Health Directorate (to Prof. Peacock); a
Hospital Infection Society Major Research Grant; and by Wellcome Trust
grant number 098051 awarded to the Wellcome Trust Sanger Institute. MET
is a Clinician Scientist Fellow supported by the Academy of Medical Sciences
and the Health Foundation and by the NIHR Cambridge Biomedical Research
Centre. The funding bodies had no role in the design of the study, the
collection, analysis, and interpretation of data, and writing of the manuscript.
Availability of data and materials
The data supporting the conclusions of this article are available in the
European Nucleotide Archive (ENA) repository under the accession numbers
provided in Additional file 1.
Authors’ contributions
Design of the study: CL, HJB, DM, MET, MC, and SJP. Wrote the study
protocols and obtained ethical and R&D approvals for the Galway and
Cambridge studies: CL, MC, HJB, and MET. Provided clinical data and
materials: MC and NMB. Provided materials: MAH. Undertook bacterial
identification and susceptibility testing for the Galway and Cambridge
Harrison et al. Genome Medicine  (2016) 8:102 Page 7 of 9
samples: CL, BB, GB, and BOC. Extracted genomic DNA: CL and HJB.
Bioinformatic analysis of whole-genome sequence data: EMH, SR, FC, and JP.
Responsible for figure production: EMH and HJB. Wrote the manuscript: EMH,
CL, HJB, and SJP. Responsible for supervision and management of the study:
DM, MC, JP, MET, and SJP. All authors read and approved the final
manuscript.
Competing interest
The authors declare that they have no competing interests.
Ethical approval and consent to participate
Study exclusion criteria were refusal to consent, being on an end-of-life care
pathway, or being agitated and resistant to personal care. Residents deemed
to have full capacity provided informed consent, while individuals who
lacked mental capacity were enrolled through a consultee. Ethical approval
for the two studies was granted by the Galway University Hospital Ethics
Committee (C.A. 717; Galway study), the NHS Health Research Authority Na-
tional Research Ethics Service (NRES; 13/LO/1278; Cambridge study), and the
Cambridge University Hospitals NHS Foundation Trust Research and Devel-
opment department (A093007; Cambridge study). All study procedures were
performed in accordance with the Declaration of Helsinki.
Author details
1Department of Medicine, University of Cambridge, Addenbrooke’s Hospital,
Box 157, Hills Road, Cambridge CB2 0QQ, UK. 2London School of Hygiene &
Tropical Medicine, Keppel Street, London WC1E 7HT, UK. 3National MRSA
Reference Laboratory, St. James’s Hospital, Dublin, Ireland. 4Antimicrobial
Resistance and Microbial Ecology (ARME) Group, School of Medicine,
National University of Ireland, Galway, Ireland. 5Cambridge University
Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. 6Public
Health England, Clinical Microbiology and Public Health Laboratory,
Addenbrooke’s Hospital, Box 236, Hills Road, Cambridge CB2 0QW, UK.
7Department of Veterinary Medicine, University of Cambridge, Cambridge,
UK. 8Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus,
Hinxton, Cambridge, UK.
Received: 20 May 2016 Accepted: 13 September 2016
References
1. Boucher H, Miller LG, Razonable RR. Serious infections caused by
methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2010;
51(Supplement 2):S183–97.
2. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a
source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med.
2001;344(1):11–6.
3. Duerden B, Fry C, Johnson AP, Wilcox MH. The control of methicillin-
resistant Staphylococcus aureus blood stream infections in England. Open
Forum Infect Dis. 2015;2(2).
4. Data on S. aureus/MRSA bloodstream infections from acute hospitals, 2004
– Q1 2016. http://www.hpsc.ie/AZ/MicrobiologyAntimicrobialResistance/
EuropeanAntimicrobialResistanceSurveillanceSystemEARSS/
ReferenceandEducationalResourceMaterial/SaureusMRSA/
LatestSaureusMRSAdata/. Accessed 26 Aug 2016.
5. NHS Commissioning Board. Everyone Counts: Planning for Patients 2013/14.
https://www.england.nhs.uk/everyonecounts/.
6. Gamblin J, Jefferies JM, Harris S, Ahmad N, Marsh P, Faust SN, Fraser S,
Moore M, Roderick P, Blair I, et al. Nasal self-swabbing for estimating the
prevalence of Staphylococcus aureus in the community. J Med Microbiol.
2013;62(Pt 3):437–40.
7. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK,
Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ. Changes in the
prevalence of nasal colonization with Staphylococcus aureus in the United
States, 2001-2004. J Infect Dis. 2008;197(9):1226–34.
8. Eveillard M, Charru P, Rufat P, Hippeaux MC, Lancien E, Benselama F,
Branger C. Methicillin-resistant Staphylococcus aureus carriage in a long-term
care facility: hypothesis about selection and transmission. Age Ageing. 2008;
37(3):294–9.
9. Murphy CR, Quan V, Kim D, Peterson E, Whealon M, Tan G, Evans K, Meyers
H, Cheung M, Lee BY, et al. Nursing home characteristics associated with
methicillin-resistant Staphylococcus aureus (MRSA) burden and transmission.
BMC Infect Dis. 2012;12:269.
10. Horner C, Wilcox M, Barr B, Hall D, Hodgson G, Parnell P, Tompkins D. The
longitudinal prevalence of MRSA in care home residents and the
effectiveness of improving infection prevention knowledge and practice on
colonisation using a stepped wedge study design. BMJ Open. 2012;2(1),
e000423.
11. Barr B, Wilcox MH, Brady A, Parnell P, Darby B, Tompkins D. Prevalence of
methicillin-resistant Staphylococcus aureus colonization among older
residents of care homes in the United Kingdom. Infect Control Hosp
Epidemiol. 2007;28(7):853–9.
12. Lee BY, Bartsch SM, Wong KF, Singh A, Avery TR, Kim DS, Brown ST, Murphy
CR, Yilmaz SL, Potter MA, et al. The importance of nursing homes in the
spread of methicillin-resistant Staphylococcus aureus (MRSA) among
hospitals. Med Care. 2013;51(3):205–15.
13. Hudson LO, Reynolds C, Spratt BG, Enright MC, Quan V, Kim D, Hannah P,
Mikhail L, Alexander R, Moore DF, et al. Diversity of methicillin-resistant
Staphylococcus aureus strains isolated from residents of 26 nursing homes in
Orange County, California. J Clin Microbiol. 2013;51(11):3788–95.
14. Horner C, Parnell P, Hall D, Kearns A, Heritage J, Wilcox M. Meticillin-resistant
Staphylococcus aureus in elderly residents of care homes: colonization rates
and molecular epidemiology. J Hosp Infect. 2013;83(3):212–8.
15. Koser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart
AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, et al. Rapid whole-
genome sequencing for investigation of a neonatal MRSA outbreak. N Engl
J Med. 2012;366(24):2267–75.
16. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, Segre
JA. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae
with whole-genome sequencing. Sci Transl Med. 2012;4(148):148ra116.
17. Tong SY, Holden MT, Nickerson EK, Cooper BS, Koser CU, Cori A, Jombart T,
Cauchemez S, Fraser C, Wuthiekanun V, et al. Genome sequencing defines
phylogeny and spread of methicillin-resistant Staphylococcus aureus in a
high transmission setting. Genome Res. 2015;25(1):111–8.
18. Price JR, Golubchik T, Cole K, Wilson DJ, Crook DW, Thwaites GE, Bowden R,
Walker AS, Peto TE, Paul J, et al. Whole-genome sequencing shows that patient-
to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in
an intensive care unit. Clin Infect Dis. 2014;58(5):609–18.
19. Ludden C, Brennan G, Morris D, Austin B, O'Connell B, Cormican M.
Characterization of methicillin-resistant Staphylococcus aureus from
residents and theenvironment in a long-term care facility. Epidemiol Infect.
2015;143(14):2985-8.
20. The European Committee on Antimicrobial Susceptibility Testing.
Breakpoint tables for interpretation of MICs and zone diameters version 5.0.
2015. http://www.eucast.org.
21. Page AJ, De Silva N, Hunt M, Quail MA, Parkhill J, Harris SR, Otto TD, Keane
JA. Robust high-throughput prokaryote de novo assembly and
improvement pipeline for Illumina data. Microb Genomics. 2016;2(8).
22. Gladman S, Seemann T, VelvetOptimiser. Australia: Victorian Bioinformatics
Consortium, Clayton; 2012. http://bioinformatics.net.au/software.
velvetoptimiser.shtml.
23. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly
using de Bruijn graphs. Genome Res. 2008;18(5):821–9.
24. Boetzer M, Henkel CV, Jansen HJ, Butler D, Pirovano W. Scaffolding pre-
assembled contigs using SSPACE. Bioinformatics. 2011;27(4):578–9.
25. Boetzer M, Pirovano W. Toward almost closed genomes with GapFiller.
Genome Biol. 2012;13(6):R56.
26. Jamrozy DM, Harris SR, Mohamed N, Peacock SJ, Tan CY, Parkhill J,
Anderson AS, Holden MTG: Pan-genomic perspective on the evolution of
the Staphylococcus aureus USA300 epidemic. Microb Genomics. 2016;2(5).
27. Milheirico C, Oliveira DC, de Lencastre H. Multiplex PCR strategy for
subtyping the staphylococcal cassette chromosome mec type IV in
methicillin-resistant Staphylococcus aureus: ‘SCCmec IV multiplex’. J
Antimicrob Chemother. 2007;60(1):42–8.
28. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of
structural types and variants of the mec element in methicillin-resistant
Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46(7):2155–61.
29. Stamatakis A, Ludwig T, Meier H. RAxML-III: a fast program for maximum
likelihood-based inference of large phylogenetic trees. Bioinformatics. 2005;
21(4):456–63.
30. Holden MT, Hsu LY, Kurt K, Weinert LA, Mather AE, Harris SR, Strommenger
B, Layer F, Witte W, de Lencastre H, et al. A genomic portrait of the
Harrison et al. Genome Medicine  (2016) 8:102 Page 8 of 9
emergence, evolution, and global spread of a methicillin-resistant
Staphylococcus aureus pandemic. Genome Res. 2013;23(4):653–64.
31. Young BC, Golubchik T, Batty EM, Fung R, Larner-Svensson H, Votintseva AA,
Miller RR, Godwin H, Knox K, Everitt RG, et al. Evolutionary dynamics of
Staphylococcus aureus during progression from carriage to disease. Proc
Natl Acad Sci U S A. 2012;109(12):4550–5.
32. Golubchik T, Batty EM, Miller RR, Farr H, Young BC, Larner-Svensson H, Fung
R, Godwin H, Knox K, Votintseva A, et al. Within-host evolution of
Staphylococcus aureus during asymptomatic carriage. PLoS One. 2013;8(5),
e61319.
33. Paterson GK, Harrison EM, Murray GGR, Welch JJ, Warland JH, Holden MTG,
Morgan FJE, Ba X, Koop G, Harris SR, et al. Capturing the cloud of diversity
reveals complexity and heterogeneity of MRSA carriage, infection and
transmission. Nat Commun. 2015;6:6560.
34. Baldwin NS, Gilpin DF, Hughes CM, Kearney MP, Gardiner DA, Cardwell C,
Tunney MM. Prevalence of methicillin-resistant Staphylococcus aureus
colonization in residents and staff in nursing homes in Northern Ireland. J
Am Geriatr Soc. 2009;57(4):620–6.
35. Shore AC, Tecklenborg SC, Brennan GI, Ehricht R, Monecke S, Coleman DC.
Panton-Valentine leukocidin-positive Staphylococcus aureus in Ireland from
2002 to 2011: 21 clones, frequent importation of clones, temporal shifts of
predominant methicillin-resistant S. aureus clones, and increasing
multiresistance. J Clin Microbiol. 2014;52(3):859–70.
36. Kinnevey PM, Shore AC, Mac Aogáin M, Creamer E, Brennan GI, Humphreys H,
Rogers TR, O’Connell B, Coleman DC. Enhanced tracking of nosocomial
transmission of endemic sequence type 22 methicillin-resistant Staphylococcus
aureus type IV isolates among patients and environmental sites by use of
whole-genome sequencing. J Clin Microbiol. 2016;54(2):445–8.
37. Kong Z, Zhao P, Liu H, Yu X, Qin Y, Su Z, Wang S, Xu H, Chen J. Whole-
genome sequencing for the investigation of a hospital outbreak of MRSA in
China. PLoS One. 2016;11(3), e0149844.
38. Simoes RR, Aires-de-Sousa M, Conceicao T, Antunes F, da Costa PM, de
Lencastre H. High prevalence of EMRSA-15 in Portuguese public buses: a
worrisome finding. PLoS One. 2011;6(3), e17630.
39. Otter JA, French GL. Survival of nosocomial bacteria and spores on surfaces and
inactivation by hydrogen peroxide vapor. J Clin Microbiol. 2009;47(1):205–7.
40. Knox J, Uhlemann AC, Miller M, Hafer C, Vasquez G, Vavagiakis P, Shi Q,
Lowy FD. Environmental contamination as a risk factor for intra-household
Staphylococcus aureus transmission. PLoS One. 2012;7(11), e49900.
41. Roberts MC, Soge OO, No D. Comparison of multi-drug resistant
environmental methicillin-resistant Staphylococcus aureus isolated from
recreational beaches and high touch surfaces in built environments. Front
Microbiol. 2013;4:74.
42. Dancer SJ. Importance of the environment in meticillin-resistant
Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet
Infect Dis. 2008;8(2):101–13.
43. Brodrick HJ, Raven KE, Harrison EM, Blane B, Reuter S, Torok ME, Parkhill J,
Peacock SJ. Whole-genome sequencing reveals transmission of
vancomycin-resistant Enterococcus faecium in a healthcare network.
Genome Med. 2016;8(1):4.
44. Votintseva AA, Miller RR, Fung R, Knox K, Godwin H, Peto TE, Crook DW,
Bowden R, Walker AS. Multiple-strain colonization in nasal carriers of
Staphylococcus aureus. J Clin Microbiol. 2014;52(4):1192–200.
45. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh
HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus
infections. Lancet Infect Dis. 2005;5(12):751–62.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Harrison et al. Genome Medicine  (2016) 8:102 Page 9 of 9
